Tamarix hispida Willd. (Tamarisk; locally known as “zhyngyl” in Kazakh) is a halophyte traditionally used for dysentery, rheumatism, and ulcers, with reported antioxidant and prolyl endopeptidase-inhibitory activities. This study investigated the phenolic profiles and biological activities of 10%, 50%, and 70% aqueous-ethanolic extracts (THU-10, THU-50, and THU-70) obtained by ultrasound-assisted extraction (UAE). Phenolic constituents were analyzed by HPLC-DAD, and antioxidant, enzyme inhibitory, anti-inflammatory, and cytotoxic activities were evaluated. Eleven phenolic compounds, including rutin, gallic acid, epicatechin, fisetin, and p-hydroxybenzaldehyde were identified, where rutin was the predominant quantified phenolic compound, reaching 2.78, 3.88, and 4.42 mg/g in THU-10, THU-50, and THU-70, respectively. THU-10 showed the strongest antioxidant activity in the ABTS and DPPH assays (IC50 = 2.13 ± 0.75 and 6.01 ± 0.30 µg/mL, respectively) and the strongest AChE and BChE inhibition (IC50 = 21.90 ± 0.70 and 38.71 ± 0.19 µg/mL, respectively). The extracts also inhibited α-amylase, α-glucosidase, and pancreatic lipase. THU-70 exhibited the strongest anti-inflammatory activity (IC50 = 18.4 ± 0.2 µg/mL). In the BSLA, the tested extracts showed no activity and were considered non-cytotoxic. UAE reduced extraction time from 48 h to 25 min and increased extract yield 3–4-fold. Overall, solvent composition significantly influenced the phenolic profiles and biological activities of T. hispida extracts.
No takes yet. Share an insight, caveat, or question.
Amanzholkyzy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: